The GSX
press release had "about 10 times higher than those in a panel of sera from patients recovering from COVID-19"
Ah...
here are the details. on
CoVLP+AS03
After 2 doses, at day 42, the neutralizing antibody (NAb) titers were roughly 2000 for both adults and older adults.
I found
a comparison of the 9 vaccines approved somewhere in the world.
It reports neutralizing antibody titer for Moderna as 654 and Pfizer as 361.
It reports the Novavax NVX-CoV2373 NAb titer as 3906
and the Clover SCB-2019 NAb titer as 1810-3320.
I do NOT know that simply having a higher NAb titer is sufficient to indicate it is a better vaccine. Obviously safety ia major factor. Also, there is an issue about being effective against variants.
"The vaccine candidate developed by Medicago, a Coronavirus-like particle (CoVLP), is a self-assembling VLP [virus-like particle] that displays trimers of recombinant S protein of SARS-CoV2 embedded into the lipid bilayer of the nanoparticles."